{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:58:09Z","timestamp":1791406689366,"version":"4.3.3"},"reference-count":124,"publisher":"Baishideng Publishing Group Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Virol"],"abstract":"<jats:p>Hepatitis A, a vaccine-preventable liver infection caused by the hepatitis A virus, is undergoing significant epidemiological shifts worldwide. Traditionally considered a disease of childhood in endemic regions, improved sanitation, economic development, and widespread vaccination have led to a decline in incidence, particularly in developed nations. However, this decline has resulted in a growing population of susceptible adults, increasing the risk of severe outbreaks. Additionally, changes in travel patterns, urbanization, and socioeconomic disparities have altered disease distribution, leading to sporadic outbreaks in low-endemicity regions and a rising burden in certain high-risk populations. This review explores the evolving epidemiology of hepatitis A, emphasizing the transition from endemic childhood infections to adult susceptibility. We examine the impact of changing risk factors, including shifting demographics, increased international travel, and regional disparities in vaccination coverage. Furthermore, the review highlights the emergence of new viral strains and their potential implications for disease control. Updated vaccination policies, including targeted immunization strategies and their role in preventing outbreaks, are also discussed. Given these dynamic changes, continued surveillance and public health preparedness tailored to evolving risk groups are crucial for sustained hepatitis A control. By synthesizing recent epidemiological data and policy updates, this review provides insights into the future of hepatitis A prevention and control, offering guidance for clinicians, researchers, and public health professionals.<\/jats:p>","DOI":"10.5501\/wjv.v14.i4.112590","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:27:54Z","timestamp":1766622474000},"source":"Crossref","is-referenced-by-count":4,"title":["Evolving trends in hepatitis A epidemiology: Shifting patterns, emerging risks, and future strategies"],"prefix":"10.5501","volume":"14","author":[{"given":"Ammara Abdul","family":"Majeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maham","family":"Sarfraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna Subhan","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"key":"B1","unstructured":"Henderson B.   FAO\/WHO Experts Rank Foodborne Viruses of Greatest Public Health Significance. 2024. Available from: https:\/\/www.food-safety.com\/articles\/10011-fao-who-experts-rank-foodborne-viruses-of-greatest-public-health-significance"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxj012"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-024-10640-2"},{"key":"B4","unstructured":"World Health Organization.   Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis. 2016. Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-HIV-2016.06"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-809633-8.90273-5"},{"key":"B6","unstructured":"Yin-Murphy M, Almond JW.   Picornaviruses. In: Baron S, editor. Medical Microbiology. 4th ed. Galveston: University of Texas Medical Branch at Galveston, 1996"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.01177-09"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/s0924-8579(02)00290-x"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268810001433"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(99)80132-6"},{"key":"B11","unstructured":"Centers for Disease Control and Prevention (CDC). Positive test results for acute hepatitis A virus infection among persons with no recent history of acute hepatitis--United States, 2002-2004. MMWR Morb Mortal Wkly Rep 2005; 453-456"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13983"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.19.1.63-79.2006"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a031708"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199201000-00002"},{"key":"B16","unstructured":"Keeffe EB. Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases. Trans Am Clin Climatol Assoc 2006; 227-37; discussion 237"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinmicnews.2020.10.001"},{"key":"B18","unstructured":"World Health Organization.   Hepatitis A: Vaccine Preventable Diseases Surveillance Standards. 2018. Available from: https:\/\/www.who.int\/publications\/m\/item\/vaccine-preventable-diseases-surveillance-standards-hepa"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4235-5"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7242a1"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00158-0"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-021-10232-4"},{"key":"B23","unstructured":"World Health Organization.   The immunological basis for immunization series: module 18: Hepatitis A. 2019. Available from: https:\/\/www.who.int\/publications\/i\/item\/97892516327"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3109\/00365549509018964"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a114243"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/s0264-410x(99)00469-7"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/11.3.464"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1086\/314518"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/BF01780769"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/s0163-4453(98)93126-7"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410x(92)90545-u"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3109\/00365549709035867"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410x(92)90557-z"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(05)80373-3"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1769389"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4161\/hv.27737"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1108\/IJHCQA-05-2019-0096"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.10.102"},{"key":"B39","unstructured":"World Health Organization.   WHO position paper on hepatitis A vaccines, October 2022. 2022. Available from: https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/policies\/position-papers\/hepatitis-a"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6806a6"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6905a1"},{"key":"B42","unstructured":"Palaisy D.   Hepatitis A immunization and high-risk populations in Canada and internationally. National Collaborating Centre for Infectious Diseases. 2022"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1590\/1980-549720200073"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268469"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2024.2370975"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-6693-5"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/s0264-410x(99)00474-0"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2411821"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.06.027"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61091509"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-10458-9"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2447643"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.25-0083"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2019.03.005"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12020116"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.5501\/wjv.v14.i2.102519"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1017\/s0950268804002857"},{"key":"B58","unstructured":"Daniels D, Grytdal S, Wasley A; Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveill Summ 2009; 1-27"},{"key":"B59","unstructured":"Poovorawan Y, Theamboonlers A, Sinlaparatsamee S, Chaiear K, Siraprapasiri T, Khwanjaipanich S, Owatanapanich S, Hirsch P. Increasing susceptibility to HAV among members of the young generation in Thailand. Asian Pac J Allergy Immunol 2000; 249-253"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.89248"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1164-9"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a031716"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.08.071"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10091081"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2024.386"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0323139"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282972"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0306293"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_1631_20"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3034-8"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.08.037"},{"key":"B72","unstructured":"Asratian AA, Melik-Andreasian GG, Mkhitarian IL, Aleksanian IuT, Shmavonian MV, Kazarian SM, Mkhitarian RG, Kozhevnikova LK. [Seroepidemiological characterization of virus hepatitis in the Republic of Armenia]. Zh Mikrobiol Epidemiol Immunobiol 2005; 93-96"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268805005194"},{"key":"B74","unstructured":"Mathur P, Arora NK. Epidemiological transition of hepatitis A in India: issues for vaccination in developing countries. Indian J Med Res 2008; 699-704"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2024.100653"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000031639"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1476748"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.5501\/wjv.v14.i1.97482"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1999.61.825"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12282"},{"key":"B81","unstructured":"Al-Aziz AM, Awad MA. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children. East Mediterr Health J 2008; 1028-1035"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.patbio.2007.09.026"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.08.034"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(05)80371-x"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1089\/fpd.2019.2648"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6818a2"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijfoodmicro.2020.108986"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28810"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.33.1700641"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.28.1800397"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1177\/1557988319895141"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.2807\/ese.16.34.19950-en"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6743a3"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268820001260"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11071271"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.2903\/sp.efsa.2013.EN-439"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902253400802"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijfoodmicro.2008.12.031"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3390\/v13101900"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taac013"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz788"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1177\/003335490912400608"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102925"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29185"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.34172\/mejdd.2023.344"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199801293380503"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2020.07.005"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad500.2127"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/4263309"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.11.023"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1007\/s11262-007-0093-0"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaf127"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-91116-7"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.24-0702"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1617004"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01327-9"},{"key":"B117","unstructured":"Nicholls M, Bruce M, Thomas J. Management of hepatitis A in a food handler at a London secondary school. Commun Dis Public Health 2003; 26-29"},{"key":"B118","unstructured":"Fortin A, Milord F. Hepatitis A in restaurant clientele and staff--Quebec. Can Commun Dis Rep 1998; 53-59"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112368"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3201\/eid2701.200316"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2024.12.006"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-09812-3"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7405a3"},{"key":"B124","unstructured":"World Health Organization.   Hepatitis A. 2025. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-a\/"}],"container-title":["World Journal of Virology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2220-3249\/full\/v14\/i4\/112590.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/2220-3249\/full\/v14\/i4\/112590.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:28:02Z","timestamp":1766622482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2220-3249\/full\/v14\/i4\/112590.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":124,"journal-issue":{"issue":"4"},"alternative-id":["112590"],"URL":"https:\/\/doi.org\/10.5501\/wjv.v14.i4.112590","relation":{},"ISSN":["2220-3249"],"issn-type":[{"value":"2220-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,25]]}}}